Valneva SE Correlations
VALN Stock | USD 3.96 0.04 1.00% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Valneva SE moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Valneva SE ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Valneva SE Correlation With Market
Good diversification
The correlation between Valneva SE ADR and DJI is -0.03 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and DJI in the same portfolio, assuming nothing else is changed.
Valneva |
Moving together with Valneva Stock
0.8 | FDMT | 4D Molecular Therapeutics | PairCorr |
0.78 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.78 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.65 | INKT | Mink Therapeutics | PairCorr |
0.8 | MREO | Mereo BioPharma Group | PairCorr |
0.86 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
0.78 | PEPG | PepGen | PairCorr |
0.7 | PIRS | Pieris Pharmaceuticals | PairCorr |
0.68 | ACRV | Acrivon Therapeutics, | PairCorr |
0.9 | ADAP | Adaptimmune Therapeutics | PairCorr |
0.71 | AFMD | Affimed NV | PairCorr |
0.63 | STOK | Stoke Therapeutics | PairCorr |
0.88 | BDTX | Black Diamond Therap | PairCorr |
0.64 | COLL | Collegium Pharmaceutical | PairCorr |
Moving against Valneva Stock
0.87 | BMY | Bristol Myers Squibb Aggressive Push | PairCorr |
0.71 | NAMS | NewAmsterdam Pharma | PairCorr |
0.45 | MNOV | MediciNova | PairCorr |
0.42 | PHVS | Pharvaris BV | PairCorr |
0.33 | ESLAW | Estrella Immunopharma | PairCorr |
0.78 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.77 | AVTE | Aerovate Therapeutics | PairCorr |
0.67 | VREX | Varex Imaging Corp | PairCorr |
0.64 | SGMO | Sangamo Therapeutics Buyout Trend | PairCorr |
0.59 | AGIO | Agios Pharm | PairCorr |
0.41 | ABEO | Abeona Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Valneva Stock performing well and Valneva SE Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Valneva SE's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
DRUG | 49.12 | 28.18 | 2.88 | (0.77) | 4.62 | 9.23 | 1,471 | |||
HPQ | 1.31 | 0.03 | 0.02 | 0.15 | 1.62 | 2.22 | 6.13 | |||
INTC | 2.36 | 0.04 | 0.07 | 0.14 | 2.58 | 6.36 | 18.29 | |||
CVX | 0.90 | 0.07 | 0.02 | 0.22 | 1.05 | 2.21 | 5.13 | |||
KO | 0.68 | (0.15) | 0.00 | (1.28) | 0.00 | 1.11 | 4.00 | |||
TRV | 1.08 | 0.15 | 0.11 | 0.27 | 1.17 | 1.93 | 11.31 | |||
JNJ | 0.61 | (0.10) | 0.00 | (0.37) | 0.00 | 1.40 | 3.25 | |||
JPM | 1.12 | (0.01) | 0.06 | 0.12 | 1.42 | 2.05 | 15.87 | |||
MSFT | 0.90 | (0.03) | (0.04) | 0.07 | 1.49 | 2.09 | 8.19 |
Valneva SE Corporate Management
Vincent Dequenne | Chief Officer | Profile | |
Frederic Jacotot | General IP | Profile | |
JuanCarlos MD | Chief Officer | Profile | |
Gerald Strohmaier | VP Resource | Profile | |
Peter Buhler | Chief Officer | Profile | |
Christian Taucher | Head Affairs | Profile |